Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The Study of MicroRNAs in Colorectal Cancer
EF 2023-24
Résumé
Colorectal cancer (CRC) is characterized by the formation of adenomas in the large intestine, accounting for approximately 10% of worldwide cancer incidences and mortality. Predisposition to CRC is caused by inactivating mutations in the tumor suppressor gene Adenomatous Polyposis Coli (APC). APC regulates many biological processes, with the canonical Wnt pathway as the most well-established one being affected by APC mutations. Dysregulation of the Wnt pathway is known to drive CRC progression. Although Wnt pathway inhibitors seem like promising therapeutic strategies, their off-target effects and toxicity to normal epithelial cells may limit their clinical application. Thus, there is an urgency to better target this pathway to reduce the burden of CRC. One increasingly attractive approach is to modulate microRNA (miRNA) expression as they only require partial complementarity with their target sequence; where a single miRNA can target multiple genes and a single gene can be targeted by multiple miRNAs. Recent studies have shown that miRNAs may play a key role in regulating CRC tumorigenesis. In this study, I aim to investigate miRNAs that directly target the APC gene, delineate their role in governing CRC growth, and whether they can lead to widespread alterations in the cells from an in vitro and in vivo perspective. Insights into the underlying mechanisms of miRNAs that regulate the Wnt pathway can provide profound information to help develop novel therapeutic modalities for CRC. In this way, treatments can be optimized to improve the quality of life, symptoms, and overall prognosis in CRC patients. Thus, the purpose of this research proposal is to investigate the roles of miRNA modulation in the context of CRC progression.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
505919
Name
Chau Stephanie T
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Study of MicroRNAs in Colorectal Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adenomatous Polyposis Coli; Apc; Cancer; Colorectal Cancer; Microrna; Mutations; Pharmacology; Tumor Supressor; Tumorigenesis; Wnt
Abstract
Colorectal cancer (CRC) is characterized by the formation of adenomas in the large intestine, accounting for approximately 10% of worldwide cancer incidences and mortality. Predisposition to CRC is caused by inactivating mutations in the tumor suppressor gene Adenomatous Polyposis Coli (APC). APC regulates many biological processes, with the canonical Wnt pathway as the most well-established one being affected by APC mutations. Dysregulation of the Wnt pathway is known to drive CRC progression. Although Wnt pathway inhibitors seem like promising therapeutic strategies, their off-target effects and toxicity to normal epithelial cells may limit their clinical application. Thus, there is an urgency to better target this pathway to reduce the burden of CRC. One increasingly attractive approach is to modulate microRNA (miRNA) expression as they only require partial complementarity with their target sequence; where a single miRNA can target multiple genes and a single gene can be targeted by multiple miRNAs. Recent studies have shown that miRNAs may play a key role in regulating CRC tumorigenesis. In this study, I aim to investigate miRNAs that directly target the APC gene, delineate their role in governing CRC growth, and whether they can lead to widespread alterations in the cells from an in vitro and in vivo perspective. Insights into the underlying mechanisms of miRNAs that regulate the Wnt pathway can provide profound information to help develop novel therapeutic modalities for CRC. In this way, treatments can be optimized to improve the quality of life, symptoms, and overall prognosis in CRC patients. Thus, the purpose of this research proposal is to investigate the roles of miRNA modulation in the context of CRC progression.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chau, Stephanie T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~